Wave Life Sciences (WVE) Asset Utilization Ratio (2015 - 2026)
Wave Life Sciences (WVE) posted Asset Utilization Ratio of 0.12 for Q1 2026, down 33.05% on a QoQ basis from 0.19 in Q2 2025, and down 43.6% year-over-year from 0.22 in Q1 2025.
Wave Life Sciences (WVE) Asset Utilization Ratio (2015 - 2026) Analysis & Trends
Wave Life Sciences' Asset Utilization Ratio history runs 12 years deep, the most recent figure standing at 0.12 for Q1 2026.
- Quarterly Asset Utilization Ratio fell 43.6% year-over-year to 0.12 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.12 (down 43.6% YoY) and the FY2025 annual result came in at 0.09, down 75.03% from the prior year.
- Asset Utilization Ratio was 0.12 for Q1 2026 at Wave Life Sciences, down from 0.19 in the prior quarter.
- Across five years, Asset Utilization Ratio topped out at 0.5 in Q2 2024 and bottomed at 0.02 in Q3 2022.
- A 5-year average of 0.23 and a median of 0.21 in 2022 frame the typical range for Asset Utilization Ratio.
- Annual changes were most pronounced in 2022 — Asset Utilization Ratio tumbled 91.15% — and 2023, when it soared 2044.08%.
- Wave Life Sciences' Asset Utilization Ratio stood at 0.02 in 2022, then surged by 2044.08% to 0.48 in 2023, then gained by 4.28% to 0.5 in 2024, then plunged by 62.76% to 0.19 in 2025, then sank by 33.05% to 0.12 in 2026.
- Business Quant data shows WVE's Asset Utilization Ratio at 0.12 in Q1 2026, 0.19 in Q2 2025, and 0.22 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.69 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 0.47 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 0.37 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Wave Life Sciences | 1.16 Bn | 612.38 Mn | - | 0.12 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.12 |
| Jun 30, 2025 | 0.19 |
| Mar 31, 2025 | 0.22 |
| Jun 30, 2024 | 0.50 |
| Mar 31, 2024 | 0.44 |
| Dec 31, 2023 | 0.48 |
| Sep 30, 2023 | 0.40 |
| Jun 30, 2023 | 0.15 |
| Mar 31, 2023 | 0.07 |
| Dec 31, 2022 | 0.02 |
| Sep 30, 2022 | 0.02 |
| Jun 30, 2022 | 0.21 |
| Mar 31, 2022 | 0.23 |
| Dec 31, 2021 | 0.20 |
| Sep 30, 2021 | 0.24 |
| Jun 30, 2021 | 0.07 |
| Mar 31, 2021 | 0.06 |
| Dec 31, 2020 | 0.07 |
| Sep 30, 2020 | 0.05 |
| Jun 30, 2020 | 0.06 |